TCM Limited
Bombay Stock ExchangeTotal Valuation
TCM Limited carries a market capitalization of 326.48M, placing it among publicly traded companies globally. Its enterprise value stands at 490.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 326.48M |
| Enterprise Value | 490.65M |
Share Statistics
TCM Limited currently has 7.48M shares outstanding.
| Shares Outstanding | 7.48M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
TCM Limited trades at a trailing price-to-earnings ratio of 314.84. The price-to-sales ratio is 1.48, and the price-to-book ratio stands at 3.92.
| PE Ratio | 314.84 |
| PS Ratio | 1.48 |
| PB Ratio | 3.92 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 2.49 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 25.67 |
Financial Position
TCM Limited maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 95.49, indicating elevated leverage, while an interest coverage ratio of -2.63 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.26 |
| Quick Ratio | 0.02 |
| Debt / Equity | 95.49 |
| Debt / EBITDA | -4.38 |
| Interest Coverage | -2.63 |
Financial Efficiency
| Return on Equity (ROE) | -77.70 |
| Return on Assets (ROA) | -7.31 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.52 |
Taxes
| Income Tax | -376,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
TCM Limited's stock has gained approximately 7.643% over the past 52 weeks. The 50-day moving average sits at 46.25, while the 200-day moving average is 51.57.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.643% |
| 50-Day Moving Average | 46.25 |
| 200-Day Moving Average | 51.57 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, TCM Limited generated 197.38M in revenue and converted that into -58.11M in net income, yielding earnings per share of -8.02. EBITDA reached -50.63M, while operating income came in at -50.63M.
| Revenue | 197.38M |
| Gross Profit | 54.52M |
| Operating Income | -50.63M |
| Pretax Income | -60.25M |
| Net Income | -58.11M |
| EBITDA | -50.63M |
| EBIT | -50.63M |
| Earnings Per Share (EPS) | -8.02 |
Balance Sheet
TCM Limited holds 8.99M in cash and equivalents against 221.65M in total debt, resulting in a net debt position of 217.26M. Total book value stands at 74.78M, with working capital of 128.83M providing operational flexibility.
| Cash & Cash Equivalents | 8.99M |
| Total Debt | 221.65M |
| Net Debt | 217.26M |
| Equity (Book Value) | 74.78M |
| Book Value Per Share | 10.02 |
| Working Capital | 128.83M |
Margins
TCM Limited operates with a gross margin of 27.62, reflecting its pricing power and cost economics. The operating margin of -25.65 and net profit margin of -29.44 provide insight into operational efficiency.
| Gross Margin | 27.62 |
| Operating Margin | -25.65 |
| Pretax Margin | -30.52 |
| Profit Margin | -29.44 |
| EBITDA Margin | -25.65 |
Stock Splits
TCM Limited's most recent stock split took place on April 26, 2022 with a 500:801 split ratio.
| Last Split Date | 4/26/2022 |
| Split Ratio | 500:801 |
Scores
TCM Limited posts an Altman Z-Score of 0.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.52 |